Physician profile
Usha Mathur Wagh
NPI 1598978371
$10,383.51
in general payments reported to CMS, 2019-2025
11 companies · $784 in 2025
The $784 reported for 2025 was more than what 75% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $1,331 · 2021: $2,878 · 2023: $5,232 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,200 · Food and Beverage: $784 · Travel and Lodging: $32.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,200.00 |
| Food and Beverage | $784.26 |
| Travel and Lodging | $32.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $8,377.49 | 2021-2025 | Cabenuva, Rukobia, Apretude |
| Gilead Sciences, INC. | $1,378.30 | 2019-2025 | |
| Janssen Products, LP | $152.60 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $141.19 | 2025 | Pifeltro |
| Janssen Biotech, INC. | $130.26 | 2019-2021 | |
| Lilly USA, LLC | $60.35 | 2025 | Zepbound, Mounjaro |
| Theratechnologies INC. | $53.03 | 2025 | Trogarzo, Egrifta |
| Emd Serono, INC. | $26.49 | 2025 | |
| Exact Sciences Corporation | $25.11 | 2025 | Cologuard Collection Kit |
| Phadia US INC. | $19.65 | 2025 | Immunocap |
| Kowa Pharmaceuticals America, INC. | $19.04 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usha Mathur Wagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.